Research at Leeds Beckett
Dr Anne Hurren
About Dr Anne Hurren
Anne joined Leeds Beckett University as a Senior Lecturer in Speech and Language Sciences in 2014 and is a HCPC registered Speech and Language Therapist. She graduated from Newcastle University in 1986 with a BSc (Hons) Speech and spent the first 3 years working with a mixed caseload of mainstream paediatrics, special schools, language unit and adult acquired disorders in hospital and community settings.
From 1989 to 2014, Anne worked as Chief Speech and Language Therapist in Sunderland, specialising in the field of ENT and Head and Neck Cancer. This included running specialist joint surgical voice restoration, dysphonia, neurolaryngology and videofluoroscopy/botulinum toxin clinics with ENT consultants.
She moved into research and teaching alongside NHS clinical practice and completed a MA in Counselling at Durham University (1999) and a PhD at Newcastle University (2014). Previous teaching has included guest lecturer in voice disorders for the BSc and MSc pre-registration programmes at Newcastle University (2000 – 2014) and post-graduate teaching for short courses and at conferences.
Additional roles included secondment to the Macmillan Surgical Voice Restoration advice line, expert panel member for the national dataset in head and neck oncology and Royal College of Speech and Language Therapists’ Advisor roles in voice disorders and laryngectomy.
Module lead for Medical Sciences 2, Clinical Analysis of Speech and Voice and Eating, Drinking and Swallowing. Additional teaching is carried out for other modules in relation to Anne’s specialist clinical areas of ENT disorders, head and neck oncology and application of counselling skills to clinical practice.
Anne’s doctoral thesis was based on the development of a new outcome measure to assess perceptual voice quality in people who have undergone laryngectomy for cancer of the larynx. Current research interests are on the continuing development of outcome measures and assessment of quality of life in head and neck cancer and voice disorders and the assessment and therapeutic management of voice disorders including neurological voice disorders e.g. Parkinson’s Disease.